phase 3 q3 2017 bpmx stated p3 for BOTH rose and acne looked to be q3 2017, lol NOPE WAY overdue and unfunded got to wonder WHY https://www.benzinga.com/analyst-ratings/analyst-color/17/03/9239423/biopharmx-cfo-talks-clinical-pipeline-ahead-of-big-q2-ca